Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.28 -0.05 (-3.76%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Current Debt (2013)

Updated

Tvardi Therapeutics' Current Debt came in at $1.46 million for Q1 2013.

Analysis

Tvardi Therapeutics (TVRD) Current Debt (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Tvardi Therapeutics 12.48 Mn 12.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 1.46 Mn
API Access

Tvardi Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TVRD&period=max&api_key=YOUR_API_KEY